2022-RA-624-ESGO OVA-LEAK: prognostic score for colo-rectal anastomotic leakage in patients undergoing ovariancancer surgery

Abstract

2022-RA-618-ESGO Table 1 Demographic and clinical characteristic of the primary and stratified cohorts Conclusion This study is the first to describe characteristics of real-world patients who initiated 1LM niraparib monotherapy based on niraparib's approval status. Study findings suggest that BRCA/HRD testing has increased over time. Moreover, understanding dosing patterns and associated treatment duration can help optimise disease management. These outcomes will be explored in the next study phase.